Regulations.gov document
Control of Nitrosamine Impurities in Human Drugs Guidance for Industry
Other · FDA-2020-D-1530 · posted Feb 25, 2021
Key facts
| Document ID | FDA-2020-D-1530-0018 |
|---|---|
| Title | Control of Nitrosamine Impurities in Human Drugs Guidance for Industry |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2020-D-1530 |
| Posted | Feb 25, 2021 |
| Comment period opens | Feb 25, 2021 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: